Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 52
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Allergy ; 72(12): 1874-1882, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28464293

RESUMEN

BACKGROUND: Ragweed pollen represents a major allergy risk factor. Ragweed extracts contain five different isoforms of the major allergen Amb a 1. However, the immunological characteristics of Amb a 1 isoforms are not fully investigated. Here, we compared the physicochemical and immunological properties of three most important Amb a 1 isoforms. METHODS: After purification, the isoforms were physicochemically characterized, tested for antibody binding and induction of human T-cell proliferative responses. Their immunological properties were further evaluated in vitro and in vivo in a mouse model. RESULTS: Amb a 1 isoforms exhibited distinct patterns of IgE binding and immunogenicity. Compared to Amb a 1.02 or 03 isoforms, Amb a 1.01 showed higher IgE-binding activity. Isoforms 01 and 03 were the most potent stimulators of patients' T cells. In a mouse model of immunization, Amb a 1.01 induced higher levels of IgG and IgE antibodies when compared to isoforms 02 and 03. Interestingly, ragweed-sensitized patients also displayed an IgG response to Amb a 1 isoforms. However, unlike therapy-induced antibodies, sensitization-induced IgG did not show IgE-blocking activity. CONCLUSION: The present study showed that naturally occurring isoforms of Amb a 1 possess different immunogenic and sensitizing properties. These findings should be considered when selecting sequences for molecule-based diagnosis and therapy for ragweed allergy. Due to its high IgE-binding activity, isoform Amb a 1.01 should be included in diagnostic tests. In contrast, due to their limited B- and T-cell cross-reactivity patterns, a combination of different isoforms might be a more attractive strategy for ragweed immunotherapy.


Asunto(s)
Alérgenos/inmunología , Ambrosia/inmunología , Antígenos de Plantas/inmunología , Fenotipo , Proteínas de Plantas/inmunología , Rinitis Alérgica Estacional/diagnóstico , Rinitis Alérgica Estacional/inmunología , Hermanos , Alérgenos/química , Ambrosia/química , Animales , Antígenos de Plantas/química , Reacciones Cruzadas/inmunología , Modelos Animales de Enfermedad , Femenino , Humanos , Sueros Inmunes/inmunología , Inmunoglobulina E/inmunología , Inmunoglobulina G/inmunología , Ratones , Extractos Vegetales/química , Extractos Vegetales/inmunología , Proteínas de Plantas/química , Isoformas de Proteínas , Linfocitos T/inmunología , Linfocitos T/metabolismo
2.
Clin Exp Allergy ; 44(3): 438-49, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24330218

RESUMEN

BACKGROUND: Trees belonging to the order of Fagales show a distinct geographical distribution. While alder and birch are endemic in the temperate zones of the Northern Hemisphere, hazel, hornbeam and oak prefer a warmer climate. However, specific immunotherapy of Fagales pollen-allergic patients is mainly performed using birch pollen extracts, thus limiting the success of this intervention in birch-free areas. OBJECTIVES: T cells are considered key players in the modification of an allergic immune response during specific immunotherapy (SIT), therefore we thought to combine linear T cell epitope-containing stretches of the five most important Fagales allergens from birch, hazel, alder, oak and hornbeam resulting in a Fagales pollen hybrid (FPH) molecule applicable for SIT. METHODS: A Fagales pollen hybrid was generated by PCR-based recombination of low IgE-binding allergen epitopes. Moreover, a structural-variant FPH4 was calculated by in silico mutagenesis, rendering the protein unable to adopt the Bet v 1-like fold. Both molecules were produced in Escherichia coli, characterized physico-chemically as well as immunologically, and tested in mouse models of allergic sensitization as well as allergy prophylaxis. RESULTS: Using spectroscopic analyses, both proteins were monomeric, and the secondary structure elements of FPH resemble the ones typical for Bet v 1-like proteins, whereas FPH4 showed increased amounts of unordered structure. Both molecules displayed reduced binding capacities of Bet v 1-specific IgE antibodies. However, in a mouse model, the proteins were able to induce high IgG titres cross-reactive with all parental allergens. Moreover, prophylactic treatment with the hybrid proteins prevented pollen extract-induced allergic lung inflammation in vivo. CONCLUSION: The hybrid molecules showed a more efficient uptake and processing by dendritic cells resulting in a modified T cell response. The proteins had a lower IgE-binding capacity compared with the parental allergens, thus the high safety profile and increased efficacy emphasize clinical application for the treatment of Fagales multi-sensitization.


Asunto(s)
Alérgenos/inmunología , Inmunoterapia , Polen/inmunología , Proteínas Recombinantes de Fusión/inmunología , Rinitis Alérgica Estacional/terapia , Tracheophyta/efectos adversos , Vacunas/inmunología , Alérgenos/química , Alérgenos/genética , Secuencia de Aminoácidos , Animales , Reacciones Cruzadas/inmunología , Células Dendríticas/inmunología , Epítopos/química , Epítopos/genética , Epítopos/inmunología , Epítopos/metabolismo , Femenino , Humanos , Inmunización , Esquemas de Inmunización , Inmunoglobulina E/inmunología , Inmunoglobulina E/metabolismo , Inmunoglobulina G/inmunología , Ratones , Datos de Secuencia Molecular , Unión Proteica/inmunología , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/genética , Rinitis Alérgica Estacional/inmunología , Alineación de Secuencia , Bazo/citología , Bazo/inmunología
3.
Eur J Surg Oncol ; 39(10): 1109-15, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23870278

RESUMEN

AIM: Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) has been proposed as treatment for advanced epithelial ovarian carcinoma (EOC). No consensus exists on when to administer CRS+HIPEC during the natural history of the disease, namely, as upfront therapy, at first recurrence, or at second or subsequent recurrence. PATIENTS AND METHODS: We analyzed a series of patients with advanced EOC collected prospectively in an institution with a peritoneal malignant disease treatment program. Patients were treated with CRS+HIPEC upfront, at first recurrence, and at second or subsequent recurrence. RESULTS: We treated 42 patients: 15 upfront, 19 at first recurrence, and 8 at second or subsequent recurrence. Cytoreduction was complete (CC0) in 75% of cases; residual disease was <2.5 mm (CC1) in 25%. Severe morbidity (CTCAE v.3.0, grade 3-4) was 26%, and hospital mortality was 7%. After a median follow-up of 24 months, median overall survival was 77.8 months for patients treated upfront, 62.8 months for patients treated at first recurrence, and 35.7 months for patients treated at second or subsequent recurrence. Disease-free survival was 21.1 months, 18 months, and 5.7 months, respectively. Overall survival in the upfront and first recurrence groups was similar, and statistically significant differences with the second recurrence group were identified (p<0.03). CONCLUSIONS: Treatment of advanced EOC using CRS+HIPEC is promising in terms of overall survival and disease-free survival when administered as upfront and at first recurrence therapy. These results warrant further evaluation in a randomized trial.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Hipertermia Inducida/métodos , Recurrencia Local de Neoplasia/tratamiento farmacológico , Recurrencia Local de Neoplasia/cirugía , Neoplasias Glandulares y Epiteliales/tratamiento farmacológico , Neoplasias Glandulares y Epiteliales/cirugía , Neoplasias Ováricas/tratamiento farmacológico , Neoplasias Ováricas/cirugía , Adulto , Anciano , Carcinoma Epitelial de Ovario , Terapia Combinada , Femenino , Humanos , Inyecciones Intraperitoneales , Persona de Mediana Edad , Recurrencia Local de Neoplasia/patología , Estadificación de Neoplasias , Neoplasias Glandulares y Epiteliales/patología , Neoplasias Ováricas/patología , Estudios Prospectivos , Tasa de Supervivencia , Resultado del Tratamiento
4.
J Phys Condens Matter ; 24(17): 175801, 2012 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-22469870

RESUMEN

Thin films of chalcopyrite AgGaSe(2) have been successfully grown on glass and glass/molybdenum substrates using the technique of chemical close-spaced vapor transport. The high crystallinity of the samples is confirmed by grazing-incidence x-ray diffraction, scanning and transmission electron microscopy, and optical transmission/reflection spectroscopy. Here, two of the three expected direct optical bandgaps are found at 1.77(2) and 1.88(6) eV at 300 K. The lowest bandgap energy at 4 K is estimated to be 1.82(3) eV. Photoluminescence spectroscopy has further revealed the nature of the point defects within the AgGaSe(2), showing evidence for the existence of very shallow acceptor levels of 5(1) and 10(1) meV, and thus suggesting the AgGaSe(2) phase itself to exhibit a p-type conductivity. At the same time, electrical characterization by Hall, Seebeck and four-point-probe measurements indicate properties of a compensated semiconductor. The electrical properties of the investigated thin films are mainly influenced by the presence of Ag(2)Se and Ga(2)O(3) nanometer-scaled surface layers, as well as by Ag(2)Se inclusions in the bulk and Ag clusters at the layers' rear side.


Asunto(s)
Galio/química , Selenio/química , Plata/química , Conductividad Eléctrica , Electroquímica/métodos , Luminiscencia , Ensayo de Materiales , Microscopía Electrónica de Rastreo/métodos , Microscopía Electrónica de Transmisión/métodos , Conformación Molecular , Nanotecnología/métodos , Óptica y Fotónica , Fotoquímica/métodos , Semiconductores , Temperatura , Difracción de Rayos X
5.
Ann Oncol ; 23(1): 211-221, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21447617

RESUMEN

BACKGROUND: Based on traditional, historical, ethnobotanical, laboratory, and clinical findings, we present research framework aiming to identify Middle Eastern herbs that are worthy of further research for their anticancer potential. METHODS: A comprehensive research project was developed by a multinational team comprising family physicians, medicine specialists, oncologists, an Islamic medicine history specialist, a traditional medicine ethnobotanist, and a basic research scientist. The project followed two consecutive phases: (i) historical and ethnobotanical search for cancer-related keywords and (ii) Medline search for in vitro and in vivo studies. RESULTS: This search yielded 44 herbs associated with cancer care. The Medline search yielded 34 herbs of which 9 herbs were reported in various clinical studies. CONCLUSIONS: This multidisciplinary survey was found to be a valuable way to identify herbs with potential clinical significance in cancer care. Based on this pilot study, it is suggested that the Middle East can serve as a valuable region for future multicultural-oriented cancer research.


Asunto(s)
Medicina Tradicional/métodos , Neoplasias/tratamiento farmacológico , Fitoterapia/métodos , Plantas Medicinales , Antineoplásicos Fitogénicos , Etnobotánica , Humanos , Medio Oriente
6.
Thorax ; 58(9): 745-51, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12947128

RESUMEN

BACKGROUND: Pulmonary rehabilitation is effective in improving exercise performance and health status in chronic obstructive pulmonary disease (COPD). However, the role of nutritional support in the enhancement of the benefits of exercise training has not been explored. A double blind, randomised, controlled trial of carbohydrate supplementation was undertaken in patients attending outpatient pulmonary rehabilitation. METHODS: 85 patients with COPD were randomised to receive a 570 kcal carbohydrate rich supplement or a non-nutritive placebo daily for the duration of a 7 week outpatient pulmonary rehabilitation programme. Primary outcome measures were peak and submaximal exercise performance using the shuttle walk tests. Changes in health status, body composition, muscle strength, and dietary macronutrient intake were also measured. RESULTS: Patients in both the supplement and placebo groups increased shuttle walking performance and health status significantly. There was no statistically significant difference between treatment groups in these outcomes. Patients receiving placebo lost weight whereas supplemented patients gained weight. In well nourished patients (BMI >19 kg/m(2)) improvement in incremental shuttle performance was significantly greater in the supplemented group (mean difference between groups: 27 (95% CI 1 to 53) m, p<0.05). Increases in incremental shuttle performance correlated with increases in total carbohydrate intake. CONCLUSIONS: When universally prescribed, carbohydrate supplementation does not enhance the rehabilitation of patients with COPD. This study suggests that exercise training results in negative energy balance that can be overcome by supplementation and that, in selected patients, this may improve the outcome of training. The finding of benefit in well nourished patients may suggest a role for nutritional supplementation beyond the treatment of weight loss in COPD.


Asunto(s)
Carbohidratos de la Dieta/administración & dosificación , Ejercicio Físico/fisiología , Enfermedad Pulmonar Obstructiva Crónica/rehabilitación , Anciano , Atención Ambulatoria , Composición Corporal , Índice de Masa Corporal , Peso Corporal , Suplementos Dietéticos , Método Doble Ciego , Ingestión de Energía , Terapia por Ejercicio , Tolerancia al Ejercicio , Femenino , Estado de Salud , Humanos , Masculino , Enfermedad Pulmonar Obstructiva Crónica/metabolismo
7.
J Microsc ; 210(Pt 1): 45-52, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12694415

RESUMEN

Nanometre-scale electron spectroscopic imaging has been applied to characterize the operation of a copper filtration plant in environmental science. Copper washed off from roofs and roads is considered to be a major contributor to diffuse copper pollution of urban environments. A special adsorber system has been suggested to control the diffusion of copper fluxes by retaining Cu with a granulated iron hydroxide. The adsorber was tested over an 18-month period on facade runoff. The concentrations range of Cu in the runoff water was measured between 10 and 1000 p.p.m. and could be reduced by between 96% and 99% in the adsorption ditch. Before the analysis of the adsorber, the suspended material from the inflow was ultracentrifuged onto TEM grids and analysed by energy-filtered transmission electron microscopy (EFTEM). Copper was found either as small precipitates 5-20 nm in size or adsorbed onto organic and inorganic particles. This Cu represents approximately 30% of the total dissolved Cu, measured by atomic emission spectrometry. To locate where the copper sorption takes place within the adsorber, the granulated iron oxide was analysed by analytical electron microscopy after exposure to the roof run-off water. A section of the granulated iron hydroxide was prepared by focused ion beam milling. The thickness of the lamina was reduced to 100 nm and analysed by EFTEM. The combination of these two techniques allowed us to observe the diffusion of Cu into the aggregate of Fe. Elemental maps of Fe and Cu revealed that copper was not only present at the surface of the granules but was also sorbed onto the fine particles inside the adsorber.

8.
J Chemother ; 14(6): 623-6, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12583555

RESUMEN

Both the etoposide, doxorubicin, cisplatin (EAP) and 5-fluorouracil, doxorubicin, high-dose methotrexate (FAMTX) schedules have been reported to be active in advanced gastric cancer. Since these regimens include non-cross resistant agents, a regimen that consists of EAP alternating with FAMTX may have an advantage over each regimen alone. We undertook a phase II trial to evaluate EAP/FAMTX in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction. Of the 56 patients treated, an objective response was observed in 34%, including complete response in 7%. Median response duration was 8 months and median survival for the entire group was 9 months. The main toxicity was myelosuppression. Hospitalization for granulocytopenic fever was required in 32% of patients and 34% required red blood cells (RBC) transfusion. Non-hematological toxicity was moderate. There were three drug-related deaths associated with granulocytopenic fever. We conclude that the alternating EAP/FAMTX regimen is associated with occasional lethal events and has no obvious advantage over either regimen alone.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias Gástricas/tratamiento farmacológico , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Cisplatino/administración & dosificación , Doxorrubicina/administración & dosificación , Etopósido/administración & dosificación , Femenino , Fluorouracilo/administración & dosificación , Humanos , Masculino , Metotrexato/administración & dosificación , Persona de Mediana Edad , Resultado del Tratamiento
9.
Curr Psychiatry Rep ; 3(6): 463-9, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11707159

RESUMEN

About 5% of women of reproductive age experience affective or physical premenstrual symptoms that markedly influence work, social activities, or relationships. Prospective charting of symptoms for at least two menstrual cycles is required to facilitate an accurate diagnosis of premenstrual syndrome or premenstrual dysphoric disorder. The optimal treatment plan begins with lifestyle modifications, followed by pharmacotherapy. Evidence from numerous controlled trials has clearly demonstrated that low-dose serotonin reuptake inhibitors, using intermittent or continuous administration, have excellent efficacy with minimal side effects. Modification of the menstrual cycle should be considered only after all other treatment options have failed.


Asunto(s)
Antidepresivos/uso terapéutico , Calcio/uso terapéutico , Magnesio/uso terapéutico , Trastornos del Humor/etiología , Trastornos del Humor/terapia , Fitoterapia , Síndrome Premenstrual/psicología , Vitamina B 6/uso terapéutico , Femenino , Humanos , Fototerapia/métodos , Vitex
10.
Urology ; 57(4 Suppl 1): 68-72, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11295598

RESUMEN

The ability to interfere with prostate carcinogenesis, and as a consequence, prevent prostate cancer with drugs is the basis for chemoprevention. The prostate contains estrogen receptors in both the stroma and epithelium. Both animal models and human epidemiologic studies have implicated estrogens as an initiator of prostate cancer. In the aging male, prostate cancer occurs in an environment of rising estrogen and decreasing androgen levels. Selective estrogen receptor modulators (SERMs) have shown the ability to prevent (GTx-006 [acapodene]) and treat (GTx-006 and arzoxifene) prostate cancer, suggesting that they may be used in prostate cancer chemoprevention. A phase 2 clinical trial using GTx-006 for prostate cancer chemoprevention is currently being conducted.


Asunto(s)
Anticarcinógenos/uso terapéutico , Isoflavonas , Neoplasias de la Próstata/prevención & control , Moduladores Selectivos de los Receptores de Estrógeno/uso terapéutico , Factores de Edad , Andrógenos/sangre , Antagonistas de Estrógenos/farmacología , Moduladores de los Receptores de Estrógeno/uso terapéutico , Estrógenos/sangre , Estrógenos no Esteroides/farmacología , Humanos , Masculino , Fitoestrógenos , Piperidinas/farmacología , Preparaciones de Plantas , Próstata/crecimiento & desarrollo , Neoplasias de la Próstata/etiología , Receptores de Estrógenos/fisiología , Tamoxifeno/farmacología , Tiofenos/farmacología
11.
J Nutr ; 131(3s): 980S-4S, 2001 03.
Artículo en Inglés | MEDLINE | ID: mdl-11238801

RESUMEN

Aged garlic extract (AGE) has been shown previously to have moderate cholesterol-lowering and blood pressure-reducing effects. We have now investigated whether platelet function, a potential risk factor for cardiovascular disease, can be inhibited by AGE administration. In a randomized, double-blind study of normal healthy individuals (n = 34), both men and women, the effect of AGE was evaluated in doses between 2.4 and 7.2 g/d vs. equal amounts of placebo. Platelet aggregation and adhesion were measured at 2-wk intervals throughout the study. Threshold concentrations for epinephrine and collagen increased moderately during AGE administration compared with the placebo and baseline periods. Only at the highest supplementation level did AGE show a slight increase in the threshold level of ADP-induced aggregation. Platelet adhesion to collagen, fibrinogen and von Willebrand factor was investigated by perfusing whole blood through a laminar flow chamber under controlled flow conditions. Adherence of platelets was inhibited by AGE in a dose-dependent manner when collagen was the adhesive surface perfused at low shear rates ( approximately 30 s(-1)). At high shear rates (1200 s(-1)), AGE also inhibited platelet adhesion to collagen but only at higher intake levels. Adhesion to von Willebrand factor was reduced only at 7.2 g/d AGE, but adherence to fibrinogen was potently inhibited at all levels of supplementation. Thus, AGE exerts selective inhibition on platelet aggregation and adhesion, platelet functions that may be important for the development of cardiovascular events such as myocardial infarction and ischemic stroke. We briefly review the effect of garlic preparations in general on cardiovascular risk factors and point out differences between AGE and other garlic preparations that we feel are important to explain the efficacy of AGE.


Asunto(s)
Enfermedades Cardiovasculares/tratamiento farmacológico , Ajo/uso terapéutico , Fitoterapia , Plantas Medicinales , Adhesividad Plaquetaria/efectos de los fármacos , Inhibidores de Agregación Plaquetaria/uso terapéutico , Agregación Plaquetaria/efectos de los fármacos , Enfermedades Cardiovasculares/prevención & control , Colágeno/sangre , Colágeno/efectos de los fármacos , Estudios Cruzados , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Epinefrina/sangre , Femenino , Fibrinógeno/análisis , Ajo/química , Humanos , Masculino , Perfusión , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Inhibidores de Agregación Plaquetaria/administración & dosificación , Inhibidores de Agregación Plaquetaria/farmacología , Factores de Riesgo , Factor de von Willebrand/análisis
12.
Nutr Cancer ; 41(1-2): 135-44, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-12094616

RESUMEN

Carnosic acid, the polyphenolic diterpene derived from rosemary, is a strong dietary antioxidant that exhibits antimutagenic properties in bacteria and anticarcinogenic activity in various cell and animal models. In the present study, we show that carnosic acid (2.5-10 microM) inhibits proliferation of HL-60 and U937 human myeloid leukemia cells (half-maximal inhibitory concentration = 6-7 microM) without induction of apoptotic or necrotic cell death. Growth arrest occurred concomitantly with a transient cell cycle block in the G1 phase, which was accompanied by an increase in the immunodetectable levels of the universal cyclin-dependent kinase inhibitors p21WAFI and p27Kipl. Carnosic acid caused only a marginal induction of differentiation, as monitored by the capacity to generate superoxide radicals and the expression of cell surface antigens (CD11b and CD14) and receptors for the chemotactic peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine. However, at low concentrations, this polyphenol substantially augmented (100- to 1,000-fold) the differentiating effects of 1,25-dihydroxyvitamin D3 and all-trans retinoic acid. Furthermore, such combinations of carnosic acid and any of these differentiation inducers synergistically inhibited proliferation and cell cycle progression. These results indicate that carnosic acid is capable of antiproliferative action in leukemic cells and can cooperate with other natural anticancer compounds in growth-inhibitory and differentiating effects.


Asunto(s)
Calcitriol/farmacología , Diferenciación Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Diterpenos/farmacología , Leucemia/patología , Extractos Vegetales/farmacología , Tretinoina/farmacología , Abietanos , Antineoplásicos Fitogénicos , Apoptosis/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Proteínas de Ciclo Celular/metabolismo , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Inhibidor p27 de las Quinasas Dependientes de la Ciclina , Ciclinas/metabolismo , Interacciones Farmacológicas , Citometría de Flujo , Fase G1/efectos de los fármacos , Células HL-60/patología , Humanos , Leucemia Mieloide/patología , Rosmarinus/química , Células Tumorales Cultivadas , Proteínas Supresoras de Tumor/metabolismo , Células U937/patología
13.
J Clin Psychiatry ; 61 Suppl 12: 22-7, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11041381

RESUMEN

Although selective serotonin reuptake inhibitors are considered the first-line treatment option for premenstrual syndrome, several other such options are also available. Multiple studies have indicated that medications that suppress ovulation alleviate premenstrual emotional and physical symptoms. However. the use of such medications, such as the gonadotropin-releasing hormone agonists, leads to prolonged low estrogen levels and cardiac and osteoporotic health risks. A recent double-blind, placebo-controlled study of 466 women with premenstrual syndrome reported that calcium was effective in reducing emotional, behavioral, and physical premenstrual symptoms. Recent preliminary trials have suggested efficacy for cognitive therapy, light therapy, and tryptophan. Future studies of diet recommendations, exercise, relaxation, magnesium, nonsteroidal anti-inflammatory drugs, diuretics, opiate antagonists, and alternative therapies are needed.


Asunto(s)
Síndrome Premenstrual/tratamiento farmacológico , Ansiolíticos/uso terapéutico , Calcio/uso terapéutico , Terapia Cognitivo-Conductual , Anticonceptivos Orales/uso terapéutico , Danazol/uso terapéutico , Estrógenos/uso terapéutico , Terapia por Ejercicio , Femenino , Humanos , Magnesio/uso terapéutico , Ovulación/efectos de los fármacos , Fototerapia , Síndrome Premenstrual/terapia , Progesterona/uso terapéutico , Terapia por Relajación , Vitamina B 12/uso terapéutico
14.
World J Urol ; 16(6): 378-83, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9870283

RESUMEN

With the emergence of minimally invasive techniques for the treatment of benign prostate hyperplasia and the need to reduce health care costs, a simple and effective prostate anesthetic block may allow more procedures to be done in an outpatient or office setting. As based on neuroanatomy studies of the prostate, the perineal approach appeared to be the best way to anesthetize the prostate. This technique was used in 43 patients who underwent interstitial laser coagulation an outpatient or office setting. The perineal prostatic block was effective for pain control whether lidocaine or lidocaine/bupivacaine was used as determined by visual analog scale, linear pain scale, or global pain questionnaire. The use of intravenous (i.v.) sedation did not influence the efficacy of the prostate anesthetic block. Thus, the perineal prostate anesthetic block may be employed in patients undergoing minimally invasive surgery for benign prostatic hyperplasia in the outpatient/office location.


Asunto(s)
Procedimientos Quirúrgicos Ambulatorios/métodos , Anestesia Local , Próstata/inervación , Hiperplasia Prostática/cirugía , Anciano , Anestesia Local/métodos , Anestésicos Locales/administración & dosificación , Endoscopía , Epinefrina/administración & dosificación , Humanos , Inyecciones , Lidocaína/administración & dosificación , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Próstata/cirugía , Prostatectomía/métodos , Resultado del Tratamiento , Vasoconstrictores/administración & dosificación
15.
J Neurol Neurosurg Psychiatry ; 65(1): 119-21, 1998 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9667573

RESUMEN

Parkinsonism as well as dystonic signs are rarely seen in central pontine myelinolysis and extrapontine myelinolysis. A 51 year old woman developed central pontine myelinolysis and extrapontine myelinolysis with parkinsonism after severe vomiting which followed alcohol and drug intake, even though marked hyponatraemia had been corrected gradually over six days. Parkinsonism resolved four months after onset, but she then exhibited persistent retrocollis, spasmodic dysphonia, and focal dystonia of her left hand. Although the medical literature documents three similar patients, this patient is different as dystonic symptoms only developed four months after parkinsonian signs had resolved.


Asunto(s)
Distonía/diagnóstico , Mielinólisis Pontino Central/diagnóstico , Enfermedad de Parkinson Secundaria/diagnóstico , Núcleo Caudado/patología , Distonía/etiología , Femenino , Humanos , Hiponatremia/complicaciones , Hiponatremia/etiología , Imagen por Resonancia Magnética , Persona de Mediana Edad , Mielinólisis Pontino Central/etiología , Examen Neurológico , Enfermedad de Parkinson Secundaria/etiología , Puente/patología , Putamen/patología , Tálamo/patología
16.
J Cardiovasc Pharmacol ; 31(6): 904-8, 1998 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9641475

RESUMEN

Garlic and some of its organosulfur components have been found to be potent inhibitors of platelet aggregation in vitro. Demonstration of their efficacy in vivo, however, especially when administered over extended periods, is sparse. We recently performed a 10-month study comparing the effect of aged garlic extract (AGE) with placebo on the lipid profiles of moderately hypercholesterolemic men. In the course of the intervention trial, we examined platelet functions and susceptibility of lipoproteins to oxidation in a subgroup of this study population. Study subjects supplemented with 7.2 AGE per day showed a significant reduction of epinephrine- and, to a lesser degree, collagen-induced platelet aggregation but failed to demonstrate an inhibition of adenosine diphosphate (ADP)-induced aggregation. Platelet adhesion to fibrinogen, measured in a laminar flow chamber at moderately high shear rate, was reduced by approximately 30% in subjects taking AGE compared with placebo supplement. A trend toward decreased susceptibility of lipoproteins to oxidation also was noted during AGE administration compared with the placebo period. We conclude that the beneficial effect of garlic preparations on lipids and blood pressure extends also to platelet function, thus providing a wider potential protection of the cardiovascular system.


Asunto(s)
Ajo , Hipercolesterolemia/tratamiento farmacológico , Peroxidación de Lípido/efectos de los fármacos , Lipoproteínas/sangre , Extractos Vegetales/uso terapéutico , Plantas Medicinales , Inhibidores de Agregación Plaquetaria/uso terapéutico , Adulto , Anciano , Método Doble Ciego , Humanos , Hipercolesterolemia/sangre , Masculino , Persona de Mediana Edad , Placebos , Extractos Vegetales/farmacología , Inhibidores de Agregación Plaquetaria/farmacología
17.
J Cell Physiol ; 172(3): 351-60, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9284955

RESUMEN

Synthetic vitamin E, dl-alpha-tocopherol, added to a human erythroleukemia HEL and a megakaryoblastic leukemia, Meg-01, cell culture produced potent dose-dependent inhibition of phorbol ester-induced adhesion and of the morphologic changes accompanying it. The inhibition was reversible by withdrawal of supplemental vitamin E from the medium. dl-alpha-Tocopherol also inhibited protein kinase C activity both at baseline and after phorbol ester stimulation. Arachidonic acid stimulated protein kinase C activity of erythroleukemia cells and promoted their adhesion, an effect that was also inhibited by dl-alpha-tocopherol. Introduction of a protein kinase C-neutralizing antibody or a protein kinase C-inhibitor substrate into permeabilized HEL cells inhibited phorbol ester-induced adhesion and shape change. dl-alpha-Tocopherol also affected the cellular distribution of protein kinase C, shifting the major portion of the enzyme to the cytosol fraction and reducing phorbol ester-induced membrane association of the enzyme. Thus, protein kinase C appears to mediate shape change and adhesion, both of which are strongly inhibited by dl-alpha-tocopherol.


Asunto(s)
Tamaño de la Célula/efectos de los fármacos , Leucemia Eritroblástica Aguda/patología , Leucemia Megacarioblástica Aguda/patología , Proteína Quinasa C/metabolismo , Acetato de Tetradecanoilforbol/antagonistas & inhibidores , Vitamina E/farmacología , Ácido Araquidónico/farmacología , Adhesión Celular/efectos de los fármacos , Membrana Celular/enzimología , Citosol/enzimología , Relación Dosis-Respuesta a Droga , Humanos , Leucemia Eritroblástica Aguda/enzimología , Leucemia Megacarioblástica Aguda/enzimología , Proteína Quinasa C/antagonistas & inhibidores , Seudópodos/efectos de los fármacos , Seudópodos/ultraestructura , Células Tumorales Cultivadas
18.
Nutr Cancer ; 28(1): 30-5, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9200147

RESUMEN

Vitamin E, best known as a potent antioxidant, has been shown to have other functions that are not mediated by this activity. Recent reports have suggested that vitamin E may inhibit smooth muscle cell and also cancer cell growth. We have studied the effect of dl-alpha-tocopherol (vitamin E) on a series of well-established cancer cell lines that included two erythroleukemia cell lines and a hormone-responsive breast and prostate cancer cell line. Cell proliferation was examined in these cell lines, which were maintained at optimal growth conditions. A dose-dependent inhibition of cell growth was found in all cell lines examined, with the MCF-7 breast and CRL-1740 prostate cancer cell lines showing potent suppression of growth at 0.1 mM vitamin E, whereas the erythroleukemia cell lines, HEL and OCIM-1, responded only at > 0.25 mM vitamin E with inhibition of proliferation. Studies of [3H]thymidine incorporation showed that vitamin E supplementation reduced DNA synthesis in all cell lines. Analysis of high-molecular-weight DNA revealed extensive fragmentation, indicating apoptosis of all cell lines supplemented with vitamin E. Our studies thus give evidence of a general inhibition of cell proliferation by dl-alpha-tocopherol, with breast and prostate cancer cells distinctly more sensitive than erythroleukemia cells.


Asunto(s)
Apoptosis/efectos de los fármacos , Neoplasias de la Mama/patología , Leucemia Eritroblástica Aguda/patología , Neoplasias de la Próstata/patología , Vitamina E/farmacología , División Celular/efectos de los fármacos , ADN/biosíntesis , Fragmentación del ADN , Electroforesis en Gel de Agar , Humanos , Masculino , Células Tumorales Cultivadas
19.
Nutr Cancer ; 28(2): 153-9, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9290121

RESUMEN

The antiproliferative potential of S-allylmercaptocysteine (SAMC), a stable organosulfur compound of aged garlic extract, has been investigated using two erythroleukemia cell lines, HEL and OCIM-1. It induces a dose-dependent inhibition of cell growth with a 50% lethal dose of 0.046 mM for OCIM-1 cells and 0.093 mM for HEL cells. [3H]thymidine incorporation was reduced in cells treated with this thioallyl compound, and analysis of high-molecular-weight DNA showed fragmentation compatible with apoptosis. Flow cytometric analyses of DNA revealed an abnormal cell cycle progression in both types of erythroleukemia cells, with the major portion of the unsynchronized cells in the G2/M phase. Measurement of acid-soluble free sulfhydryl groups showed an initial increase in response to SAMC followed by a progressive dose-dependent decrease with extended incubation of cells. We conclude from these studies that SAMC is an effective antiproliferative agent against erythroleukemia cells that induces cell death by apoptosis.


Asunto(s)
Apoptosis/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Cisteína/análogos & derivados , Leucemia Eritroblástica Aguda/patología , Apoptosis/fisiología , Ciclo Celular/fisiología , División Celular/efectos de los fármacos , División Celular/fisiología , Cisteína/toxicidad , ADN/análisis , ADN/genética , Fragmentación del ADN/efectos de los fármacos , Fragmentación del ADN/genética , Relación Dosis-Respuesta a Droga , Citometría de Flujo , Ajo , Humanos , Leucemia Eritroblástica Aguda/genética , Plantas Medicinales , Compuestos de Sulfhidrilo/análisis , Timidina/metabolismo , Tritio , Células Tumorales Cultivadas
20.
Am J Clin Nutr ; 64(6): 866-70, 1996 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8942410

RESUMEN

A double-blind crossover study comparing the effect of aged garlic extract with a placebo on blood lipids was performed in a group of 41 moderately hypercholesterolemic men [cholesterol concentrations 5.7-7.5 mmol/L (220-290 mg/dL)]. After a 4-wk baseline period, during which the subjects were advised to adhere to a National Cholesterol Education Program Step I diet, they were started on 7.2 g aged garlic extract per day or an equivalent amount of placebo as a dietary supplement for a period of 6 mo, then switched to the other supplement for an additional 4 mo. Blood lipids, blood counts, thyroid and liver function measures, body weight, and blood pressure were followed over the entire study period. The major findings were a maximal reduction in total serum cholesterol of 6.1% or 7.0% in comparison with the average concentration during the placebo administration or baseline evaluation period, respectively. Low-density-lipoprotein cholesterol was also decreased by aged garlic extract, 4% when compared with average baseline values and 4.6% in comparison with placebo period concentrations. In addition, there was a 5.5% decrease in systolic blood pressure and a modest reduction of diastolic blood pressure in response to aged garlic extract. We conclude that dietary supplementation with aged garlic extract has beneficial effects on the lipid profile and blood pressure of moderately hypercholesterolemic subjects.


Asunto(s)
Ajo , Hipercolesterolemia/sangre , Lípidos/sangre , Plantas Medicinales , Adulto , Anciano , Presión Sanguínea/fisiología , Peso Corporal/fisiología , Colesterol/sangre , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Estudios Cruzados , Método Doble Ciego , Humanos , Hipercolesterolemia/fisiopatología , Hígado/fisiología , Masculino , Persona de Mediana Edad , Glándula Tiroides/fisiología , Triglicéridos/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA